Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis
- PMID: 22110170
- PMCID: PMC3220864
- DOI: 10.2337/dc11-1584
Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis
Abstract
Objective: Diabetes has been associated with chronic neurodegeneration. We performed a systematic review and meta-analysis to assess the relationship between pre-existing diabetes and Parkinson's disease (PD).
Research design and methods: Original articles in English published up to 10 May 2011 were searched for in electronic databases (PubMed, Embase, and Scopus) and by reviewing references of eligible articles. Prospective cohort and case-control studies providing risk and precision estimates relating to pre-existing diabetes and PD were considered eligible.
Results: Nine studies/1,947 citations (cohort, N = 4; case-control, N = 5) fulfilled inclusion criteria for meta-analysis. In prospective studies, the onset of diabetes before onset of PD was found to be a risk factor for future PD (relative risk [RR] = 1.37 [95%CI 1.21-1.55]; P < 0.0001). This association was confirmed by secondary analyses based on estimates derived after the exclusion of participants who had vascular disease at baseline and/or who developed vascular disease during follow-up (RR = 1.34 [1.14-1.58]; P < 0.001) and by sensitivity analyses addressing the association with diabetes at baseline or during follow-up. However, the association found for case-control studies was not significant (odds ratio [OR] 0.75 [95%CI 0.50-1.11]; P = 0.835). Sensitivity analysis based on estimates adjusted for BMI confirmed the lack of a relationship between PD and diabetes (OR 0.56 [0.28-1.15]; P = 0.089).
Conclusions: Although data from cohort studies suggest that diabetes is a risk factor for PD, there is no conclusive evidence on this association. Further prospective studies focused on putative pathogenic pathways and taking a broad range of confounders into account is required to clarify this relationship.
Figures
Similar articles
-
Association between diabetes mellitus and risk of Parkinson's disease: A prisma-compliant meta-analysis.Brain Behav. 2021 Aug;11(8):e02082. doi: 10.1002/brb3.2082. Epub 2021 Jul 21. Brain Behav. 2021. PMID: 34291588 Free PMC article.
-
Diabetes mellitus, prediabetes and the risk of Parkinson's disease: a systematic review and meta-analysis of 15 cohort studies with 29.9 million participants and 86,345 cases.Eur J Epidemiol. 2023 Jun;38(6):591-604. doi: 10.1007/s10654-023-00970-0. Epub 2023 Apr 25. Eur J Epidemiol. 2023. PMID: 37185794 Free PMC article. Review.
-
Risk of Parkinson Disease in Diabetes Mellitus: An Updated Meta-Analysis of Population-Based Cohort Studies.Medicine (Baltimore). 2016 May;95(18):e3549. doi: 10.1097/MD.0000000000003549. Medicine (Baltimore). 2016. PMID: 27149468 Free PMC article.
-
Parkinson's disease and risk of mortality: meta-analysis and systematic review.Acta Neurol Scand. 2014 Feb;129(2):71-9. doi: 10.1111/ane.12201. Epub 2013 Nov 20. Acta Neurol Scand. 2014. PMID: 24256347 Review.
-
Diabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studies.PLoS One. 2014 Jan 21;9(1):e85781. doi: 10.1371/journal.pone.0085781. eCollection 2014. PLoS One. 2014. PMID: 24465703 Free PMC article.
Cited by
-
Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes.Brain. 2020 Oct 1;143(10):3067-3076. doi: 10.1093/brain/awaa262. Brain. 2020. PMID: 33011770 Free PMC article.
-
The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases.Drug Des Devel Ther. 2022 Mar 14;16:665-684. doi: 10.2147/DDDT.S348055. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35340338 Free PMC article. Review.
-
18F-FP-CIT dopamine transporter PET findings in the striatum and retina of type 1 diabetic rats.Ann Nucl Med. 2023 Apr;37(4):219-226. doi: 10.1007/s12149-022-01818-5. Epub 2023 Jan 6. Ann Nucl Med. 2023. PMID: 36609801
-
Diabetic retinopathy as a potential marker of Parkinson's disease: a register-based cohort study.Brain Commun. 2021 Nov 8;3(4):fcab262. doi: 10.1093/braincomms/fcab262. eCollection 2021. Brain Commun. 2021. PMID: 34806000 Free PMC article.
-
Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease.PLoS One. 2014 Oct 3;9(10):e109042. doi: 10.1371/journal.pone.0109042. eCollection 2014. PLoS One. 2014. PMID: 25279756 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical